CUMBERLAND PHARMACEUTICALS INC — All Filings
1,003 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
10-Q/A
3
3/A
4
4/A
424B4
424B5
5
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFR14A
DEL AM
EFFECT
REGDEX
S-1
S-1/A
S-3
S-3/A
S-8
SC 13G
SC 13G/A
SC TO-I
SC TO-I/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 | 0001087294-26-000040 | Mar 20, 2026 | Mar 18, 2026 |
| 4 | FORM 4 | 0001632384-26-000002 | Mar 20, 2026 | Mar 18, 2026 |
| 4 | FORM 4 | 0001087294-26-000039 | Mar 20, 2026 | Mar 18, 2026 |
| 4 | FORM 4 | 0001087294-26-000037 | Mar 20, 2026 | Mar 18, 2026 |
| 4 | FORM 4 | 0001087294-26-000036 | Mar 20, 2026 | Mar 18, 2026 |
| 4 | FORM 4 | 0001087294-26-000035 | Mar 20, 2026 | Mar 18, 2026 |
| 4 | FORM 4 | 0001087294-26-000034 | Mar 20, 2026 | Mar 18, 2026 |
| 4 | FORM 4 | 0001087294-26-000033 | Mar 20, 2026 | Mar 18, 2026 |
| 4 | FORM 4 | 0001572342-26-000002 | Mar 20, 2026 | Mar 18, 2026 |
| 4 | FORM 4 | 0001087294-26-000032 | Mar 20, 2026 | Mar 18, 2026 |
| 4 | FORM 4 | 0001628280-26-019514 | Mar 18, 2026 | Mar 16, 2026 |
| ARS | ARS | 0001087294-26-000029 | Mar 12, 2026 | — |
| DEFA14A | DEFA14A | 0001087294-26-000027 | Mar 9, 2026 | — |
| DEF 14A | DEF 14A | 0001087294-26-000025 | Mar 9, 2026 | Dec 31, 2025 |
| 10-K | 10-K | 0001087294-26-000020 | Mar 9, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001087294-26-000015 | Mar 3, 2026 | — |
| SCHEDULE 13G | — | 0001075050-26-000006 | Feb 9, 2026 | — |
| 8-K | 8-K | 0001087294-26-000011 | Feb 4, 2026 | — |
| 4 | FORM 4 | 0001087294-26-000008 | Jan 6, 2026 | Dec 1, 2025 |
| 4 | FORM 4 | 0001087294-26-000006 | Jan 6, 2026 | Dec 1, 2025 |
| 4 | FORM 4 | 0001087294-26-000004 | Jan 6, 2026 | Dec 1, 2025 |
| 4 | FORM 4 | 0001087294-26-000002 | Jan 6, 2026 | Dec 1, 2025 |
| 4 | FORM 4 | 0001087294-25-000029 | Dec 1, 2025 | Nov 3, 2025 |
| 4 | FORM 4 | 0001490829-25-000007 | Dec 1, 2025 | Nov 3, 2025 |
| 4 | FORM 4 | 0001087294-25-000027 | Dec 1, 2025 | Nov 3, 2025 |
| 4 | FORM 4 | 0001087294-25-000025 | Dec 1, 2025 | Nov 3, 2025 |
| 8-K | 8-K | 0001087294-25-000023 | Nov 24, 2025 | Nov 18, 2025 |
| 10-Q | 10-Q | 0001087294-25-000020 | Nov 7, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001087294-25-000017 | Nov 4, 2025 | — |
| 4 | FORM 4 | 0001684087-25-000008 | Nov 3, 2025 | Oct 1, 2025 |
| 4 | FORM 4 | 0001490829-25-000005 | Nov 3, 2025 | Oct 1, 2025 |
| 4 | FORM 4 | 0001075050-25-000006 | Nov 3, 2025 | Oct 1, 2025 |
| 4 | FORM 4 | 0001695580-25-000004 | Nov 3, 2025 | Oct 1, 2025 |
| SCHEDULE 13G/A | — | 0001104659-25-104396 | Oct 30, 2025 | — |
| 8-K | 8-K | 0001087294-25-000012 | Oct 21, 2025 | — |
| 4 | FORM 4 | 0001684087-25-000004 | Oct 3, 2025 | Sep 2, 2025 |
| 4 | FORM 4 | 0001087294-25-000008 | Oct 3, 2025 | Sep 2, 2025 |
| 4 | FORM 4 | 0001087294-25-000007 | Oct 3, 2025 | Sep 2, 2025 |
| 4 | FORM 4 | 0001087294-25-000006 | Oct 3, 2025 | Sep 2, 2025 |
| 4 | FORM 4 | 0001628280-25-041989 | Sep 12, 2025 | Aug 1, 2025 |
| 4 | FORM 4 | 0001628280-25-041987 | Sep 12, 2025 | Aug 1, 2025 |
| 4 | FORM 4 | 0001628280-25-041985 | Sep 12, 2025 | Aug 1, 2025 |
| 4 | FORM 4 | 0001628280-25-041983 | Sep 12, 2025 | Aug 1, 2025 |
| UPLOAD | — | 0000000000-25-009049 | Aug 25, 2025 | — |
| CORRESP | — | 0001628280-25-040570 | Aug 15, 2025 | — |
| 4 | FORM 4 | 0001628280-25-039411 | Aug 11, 2025 | Jul 1, 2025 |
| 4 | FORM 4 | 0001628280-25-039404 | Aug 11, 2025 | Jul 1, 2025 |
| 4 | FORM 4 | 0001628280-25-039400 | Aug 11, 2025 | Jul 1, 2025 |
| 4 | FORM 4 | 0001628280-25-039397 | Aug 11, 2025 | Jul 1, 2025 |
| 10-Q | 10-Q | 0001628280-25-039326 | Aug 8, 2025 | Jun 30, 2025 |